查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1849800

細胞治療包裝市場:2035年前的產業趨勢全球預測:各包裝治療類型，各包裝設計，各產業規模，主要地區

Cell Therapy Packaging Market by Type of Therapy Packed, Package Engineering Design, Scale of Operation and Key Geographical Regions: Industry Trends and Global Forecasts, Till 2035
出版日期: | 出版商: Roots Analysis | 英文 204 Pages | 商品交期: 最快1-2個工作天內

價格

全球細胞療法包裝市場預計將從目前的 4.04 億美元增長至 2035 年的 12.25 億美元，預測期內複合年增長率 (CAGR) 為 11.7%。

市場區隔包括基於以下參數的市場規模和機會分析：

依療法類型包裝

  • T細胞治療
  • 樹突狀細胞疫苗
  • 幹細胞治療
  • NK細胞治療
  • 其他的先進治療藥

事業規模

  • 臨床規模
  • 商業規模

包裝設計

  • 一次包裝
  • 二次包裝

主要地區

  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

細胞療法包裝市場成長與趨勢

多年來，製藥業在藥物研發方面取得了許多進展。該領域正從通用治療方案轉向更個人化的治療方式，將個人化細胞療法應用於各種疾病適應症。這一轉變也為製藥包裝產業帶來了顯著變化。細胞療法藥物的包裝往往比小分子藥物或其他生物製劑更為複雜。為了在超低溫和嚴格的品質標準下維持細胞的無菌性和活性，需要特定的填充、儲存和運輸條件。細胞療法管理的複雜性使得研發人員必須制定包裝和運輸這些療法的策略計畫。

近期，多家開發商與產業利害關係人建立了策略合作夥伴關係，以確保細胞療法的無菌性和質量，從而保障治療介入措施的保存、運輸和完整性。值得注意的是，服務供應商正在不斷改進包裝技術，超越傳統包裝產品，以滿足冷鍊和超低溫環境的要求，從而維持這些新型尖端療法的穩定性。自動化、人工智慧驅動的分析、封閉式生產系統、CRISPR基因編輯和改進的病毒載體技術等創新技術提高了效率，降低了污染風險，降低了成本，並實現了複雜療法的規模化生產。因此，預計在預測期內，對細胞療法的需求不斷增長將顯著推動細胞療法包裝服務市場的成長。

細胞療法包裝市場關鍵洞見

本研究報告分析了細胞療法包裝市場的現狀，並指出了潛在的成長機會。報告的主要發現包括：

  • 多家公司聲稱具備包裝各種類型細胞療法的能力。 其中，94% 的公司在產品開發的各個階段提供多種附加服務。
Cell Therapy Packaging Market-IMG1
  • 該領域利害關係人提供的服務中，近 90% 是細胞療法的被動包裝，其中近 50% 提供低溫範圍內的乾式運輸箱作為被動包裝系統。
Cell Therapy Packaging Market-IMG2
  • 超過30家公司提供各種形式的細胞療法包裝服務，其中大多數公司總部位於北美。
  • 近50%的細胞療法包裝產品是用於儲存和保護藥物的包裝袋，其中71%的產品提供低溫包裝。
  • 為了追求競爭優勢，該領域的利害關係人正在積極提升現有能力並加強其包裝相關服務組合。
  • 自2016年以來，該領域的合作活動顯著增加，最近的大多數合作都集中在包裝技術/平台的整合上。
  • 隨著未來預計會有更多細胞療法獲得批准，開發商可能會與合約服務提供者建立策略合作夥伴關係，並將部分營運外包。
  • 為了滿足日益增長的細胞療法產品需求，製造商正在世界各地建立生產基地，而美國目前正崛起為細胞療法的主要生產地。
Cell Therapy Packaging Market-IMG3
  • 市場成長很可能是由細胞療法需求的不斷成長所驅動。預計未來的成長機會將涵蓋各種規模和地理的企業。

細胞療法包裝市場的主要細分市場

T細胞療法細分市場佔細胞療法包裝市場最大的佔有率

根據包裝的療法類型，市場可細分為T細胞療法、樹突細胞癌症疫苗、幹細胞療法、NK細胞療法和其他先進療法。由於T細胞療法在癌症治療方面已被證實有效，因此目前佔細胞療法包裝市場最大的佔有率。預計這一趨勢在未來幾年將保持不變。

在預測期內，商業規模細分市場將成為細胞療法包裝市場成長最快的細分市場。

根據營運規模，市場可細分為臨床規模和商業規模。儘管臨床規模佔了更高的市場佔有率，但值得注意的是，商業規模市場預計在未來幾年將實現顯著成長。

目前，初級包裝佔細胞治療包裝市場的最大佔有率。

依包裝設計，市場分為初級包裝和二級包裝。目前，初級包裝佔細胞治療包裝市場的最大佔有率，預計未來幾年這一趨勢將保持不變。這可能是由於初級包裝具有許多優勢，例如保護性、易用性、成本效益和劑量管理。

亞太地區佔最大的市佔率。

依主要地區劃分，市場分為北美、歐洲、亞太地區及亞太其他地區。值得注意的是，預計未來幾年歐洲市場的複合年增長率將更高。

主要研究概論

  • 德國，小型企業，承包商和所有者
  • 德國，小型企業，財務長
  • 美國，小型企業，首席商務官
  • 美國，小型公司，科學事務與技術行銷資深總監
  • 愛爾蘭，大型公司，勝肽類副總裁
  • 日本，大型公司，勝肽類業務專案負責人和高階經理

細胞治療包裝市場參與企業案例

  • Almac
  • Catalent Biologics
  • Cryoport Systems
  • Saint-Gobain
  • Thermo Fisher Scientific
  • West Pharmaceuticals
  • Yourway

細胞治療包裝市場調查對象

  • 市場規模和機會分析：本報告對市場規模和機會進行了深入分析。細胞療法包裝市場，重點關注關鍵細分市場，例如[A] 包裝的療法類型，[B] 企業規模，[C] 包裝設計，以及[D] 主要地區。
  • 市場概況（服務提供者）：對細胞療法包裝服務提供者進行全面評估，考慮各種參數，包括[A] 成立年份，[B] 公司規模，[C] 總部所在地，[D] 提供的服務類型，[E] 包裝類型，[F] 提供的被動系統類型，[F] 包裝工程設計，以及[G] 使用的相變材料。
  • 市場概況（細胞療法包裝產品）：對細胞療法包裝產品進行全面評估，考慮各種參數，包括[A] 包裝容器類型，[B] 容器製造材料類型，[C] 容器製造原料，[D] 包裝的細胞類型，[E] 儲存條件，以及[F] 容器的易用性。它還包括基於多個參數對產品供應商的詳細分析，例如[G]成立年份、[H]公司規模、[I]總部所在地以及[J]最活躍的參與者（按產品數量計）。
  • 公司簡介：提供主要細胞治療包裝產品和服務公司的詳細簡介，重點關注A]公司概況、[B]服務/產品組合、[C]近期發展以及[D]未來展望。
  • 競爭分析：透過考察A]公司服務能力、[B]包裝產品組合以及[C]服務組合等因素，對細胞治療包裝服務提供者進行全面的競爭分析。
  • 合作夥伴關係與合作：基於多個參數分析自2016年以來該領域形成的聯盟，例如聯盟成立年份、聯盟類型（服務聯盟、技術/平台整合協議、併購）、聯盟目的、提供的服務類型以及參與聯盟的參與者所在地區。
  • 潛在合作夥伴分析：對超過 250 家可能與細胞療法包裝供應商合作的細胞療法開發公司進行深入評估。此分析考慮了各種相關參數，例如 [A] 開發商實力（基於公司規模）、[B] 療法類型、[C] 研發管線成熟度（基於候選藥物的研發階段）等。
  • 案例研究：[A] 公司成立年份、[B] 公司規模、[C] 總部所在地、[D] 生產設施所在地。此外，還包括對 [E] 生產的細胞類型、[F] 細胞來源、[G] 業務規模和 [H] 生產能力/服務的詳細分析。

目錄

第1章 序文

第2章 摘要整理

第3章 簡介

  • 章概要
  • 醫藥品填充包裝
  • 醫藥品包裝的重要性
  • 醫藥品包裝的種類
  • 細胞治療的包裝
    • 一次包裝
    • 二次包裝
  • 細胞治療包裝:重要的考慮事項
  • 細胞治療包裝相關的課題
  • 結論

第4章 細胞治療包裝服務供應商:市場形勢

  • 章概要
  • 細胞治療包裝服務供應商:市場形勢

第5章 細胞治療包裝產品供應商:市場形勢

  • 章概要
  • 細胞治療包裝產品:市場形勢
  • 細胞治療包裝:產品供應商的形勢

第6章 細胞治療包裝服務及產品供應商:企業簡介

  • 章概要
  • 細胞治療包裝服務供應商
    • Almac
    • Catalent Biologics
    • Cryoport Systems
    • Yourway
  • 細胞治療包裝產品供應商
    • Saint-Gobain Life Sciences
    • Thermo Fisher Scientific
    • West Pharmaceutical Services

第7章 企業競爭力分析

  • 章概要
  • 主要的參數
  • 調查手法
  • 細胞治療包裝服務供應商:企業競爭力分析
    • 北美企業
    • 歐洲和亞太地區的企業

第8章 夥伴關係和合作

  • 章概要
  • 夥伴關係模式
  • 細胞治療包裝:夥伴關係和合作的清單

第9章 合作夥伴候補的分析

  • 章概要
  • 範圍與調查手法
  • 北美的細胞治療包裝供應商的潛在的策略性合作夥伴
  • 歐洲的細胞治療包裝供應商的潛在的策略性合作夥伴
  • 亞太地區及其他地區的細胞治療包裝供應商的潛在的策略性合作夥伴

第10章 細胞治療的開發商和製造商:案例研究

  • 章概要
  • 細胞治療廠商:市場形勢

第11章 全球細胞治療包裝市場

第12章 細胞治療包裝市場(各治療類型)

第13章 細胞治療包裝市場(各產業規模)

第14章 細胞治療用包裝市場(各包裝設計)

第15章 細胞治療包裝市場(各主要地區)

第16章 結論

第17章 附錄1:表格形式資料

第18章 附錄2:企業·團體一覽

Product Code: RA100279

Cell Therapy Packaging Market: Overview

As per Roots Analysis, the global cell therapy packaging market is estimated to grow from USD 404 million in the current year to USD 1,225 million by 2035, at a CAGR of 11.7% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Therapy Packed

  • T-cell Therapies
  • Dendritic Cell Vaccines
  • Stem Cell Therapies
  • NK-cell Therapies
  • Other Advanced Therapy Medicinal Products

Scale of Operations

  • Clinical Scale
  • Commercial Scale

Package Engineering Design

  • Primary Packaging
  • Secondary Packaging

Key Geographical Regions

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Cell Therapy Packaging Market: Growth and Trends

Over the years, the pharmaceutical industry has witnessed several advancements in drug development. The domain has transitioned from a universal treatment alternative to a more tailored approach to therapy, incorporating personalized cell therapies for various disease indications. This transition has resulted in a notable shift in the pharmaceutical packaging sector as well. The packaging of cell therapies tends to be more intricate compared to small molecule therapeutics and other biologics. It necessitates specific conditions for fill / finish, storage, and transportation to preserve the sterility and viability of cells at cryogenic temperatures and strict quality standards. Due to the intricacies involved in managing cell therapies, it is essential for developers to create a strategic plan for packaging and transporting these therapies.

In the recent past, to ensure the sterility and quality of cell therapies, several developers have forged strategic partnerships with industry stakeholders to ensure the integrity of their therapeutic intervention in addition to their storage and transport. It is worth highlighting that the service providers are steadily advancing their packaging technologies beyond the conventional packaging products to meet the demand for cold chain and cryogenic environment required to maintain the stability of these novel, state-of-the-art therapies. Innovations such as automation, AI-driven analytics, closed-system production, CRISPR gene editing, and improved viral vector technologies enhance efficiency, reduce contamination risks, and lower costs, enabling scalable manufacturing for complex therapies. Thus, owing to the rising demand for cell-based therapeutics, the market for cell therapy packaging services is expected to witness substantial growth during the forecast period.

Cell Therapy Packaging Market: Key Insights

The report delves into the current state of the cell therapy packaging market and identifies potential growth opportunities within industry. Some key findings from the report include:

  • Several industry players claim to have the required capabilities for packaging of different types of cell therapies; of these, 94% of the firms offer multiple additional services across different stages of product development.
Cell Therapy Packaging Market - IMG1
  • Close to 90% of the services offered by the stakeholders in this domain are for passive packaging of cell therapies; of these, nearly 50% of the players offer dry shippers as the passive system at cryogenic temperature range.
Cell Therapy Packaging Market - IMG2
  • Over 30 companies offer packaging services for cell therapies in various formats; majority of these firms are headquartered in North America.
  • Nearly, 50% of the cell therapy packaging products are bags used for storage and protection of drugs; further 71% of these products offer packaging products at cryogenic temperature ranges.
  • In pursuit of a competitive edge, stakeholders in this domain are actively upgrading their existing capabilities and enhancing packaging-related service portfolios.
  • Since 2016, there has been a marked increase in the partnership activity in this domain; most of the recent collaborations are focused on the packaging technology / platform integration.
  • As more cell therapies are anticipated to receive approval in future, developers are anticipated to forge strategic partnerships with contract service providers to outsource a part of their business operations.
  • In order to meet the rising demand for cell therapy products, manufacturers have established their presence in various regions across the world; presently, the US emerged as the key manufacturing hub for cell therapies.
Cell Therapy Packaging Market - IMG3
  • The market's growth is likely to be driven by the rising demand for cell therapies; the future opportunity is expected to be well distributed across various scales of operation and geographies.

Cell Therapy Packaging Market: Key Segments

T-Cell Therapies Segment Occupies the Largest Share of the Cell Therapy Packaging Market

Based on the type of therapy packed, the market is segmented into T-cell therapies, dendritic cell cancer vaccines, stem cell therapies, NK-cell therapies, and other advanced therapy medicinal products. Owing to their proven efficacy in treating cancer effectively, the T-cell therapies segment holds the maximum share of the current cell therapy packaging market. This trend is likely to remain the same in the forthcoming years.

Commercial Scale Segment is the Fastest Growing Segment of the Cell Therapy Packaging Market During the Forecast Period

Based on the scale of operation, the market is segmented into clinical and commercial scale. While clinical accounts for a higher market share, it is worth highlighting that the commercial scale segment is expected to witness substantial market growth in the coming years.

Currently, the Primary Packaging Segment Occupies the Largest Share of the Cell Therapy Packaging Market

Based on the package engineering designs, the market is segmented into primary and secondary packaging. At present, primary packaging holds the maximum share of the cell therapy packaging market and this trend is likely to remain the same in the forthcoming years. This can be attributed to the numerous advantages of primary packaging, such as protection, ease of use, cost-effectiveness and dosage control.

Asia-Pacific Accounts for the Largest Share of the Market

Based on the key geographical regions, the market is segmented into North America, Europe, Asia-Pacific and the Rest of the world. It is worth highlighting that, over the years, the market in Europe is expected to grow at a higher CAGR.

Primary Research Overview

  • Founder and Owner, Small Company, Germany
  • Chief Financial Officer, Small Company, Germany
  • Chief Business Officer, Small Company, US
  • Senior Director of Scientific Affairs and Technical Marketing, Small Company, US
  • Vice President, Peptides, Large Company, Ireland
  • Senior Manager, Peptide Business Project Leader, Large Company, Japan

Example Players in the Cell Therapy Packaging Market

  • Almac
  • Catalent Biologics
  • Cryoport Systems
  • Saint-Gobain
  • Thermo Fisher Scientific
  • West Pharmaceuticals
  • Yourway

Cell Therapy Packaging Market: Research Coverage

  • Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the cell therapy packaging market, focusing on key market segments, including [A] type of therapy packed, [B] scale of operation, [C] package engineering design and [D] key geographical regions.
  • Market Landscape (Service Providers): A comprehensive evaluation of cell therapy packaging services providers, considering various parameters, such as [A] year of establishment, [B] company size, [C] location of headquarters, [D] type of services offered, [E] type of packaging, [F] type of passive system offered, [F] packaging engineering design, [G] phase change material used.
  • Market Landscape (Cell Therapy Packaging Products): A comprehensive evaluation of cell therapy packaging products, considering various parameters, such as [A] type of packaging container, [B] type of container fabrication material, [C] raw materials for container fabrication, [D] type of cells packed, [E] storage conditions, and [F] usability of container. It also includes a detailed analysis on product providers on the basis of multiple parameters, such as their [G] year of establishment, [H] company size, [I] location of headquarters and [J] most active players (in terms of number of products).
  • Company Profiles: In-depth profiles of key industry players offering cell therapy packaging products and services, focusing on [A] company overviews, [B] service / product portfolio, [C] recent developments and [D] an informed future outlook.
  • Company Competitiveness Analysis: A comprehensive competitive analysis of cell therapy packaging service providers, examining factors, such as [A] service strength of a company, [B] packaging portfolio and [C] service portfolio.
  • Partnerships and Collaborations: An analysis of partnerships established in this sector, since 2016, based on several parameters, such as year of partnership, type of partnership (service alliance, technology / platform integration agreement, merger and acquisition), purpose of partnership, type of service offered, and geographical location of players involved in the partnership.
  • Likely Partner Analysis: A detailed evaluation of over 250 cell therapy developers that are most likely to collaborate with cell therapy packaging providers. This analysis considers various relevant parameters, including [A] developer strength (based on company size), [B] type of therapy and [C] pipeline maturity (based on stage of development of drug candidates).
  • Case Study: A case study highlighting the companies that are engaged in the development and manufacturing of cell therapies, along with the information on their [A] year of establishment, [B] company size, [C] location of headquarters and [D] location of manufacturing facility. Further, the chapter includes a detailed analysis on [E] type of cells manufactured, [F] source of cells, [G] scale of operation and [H] manufacturing capabilities / services of the aforementioned companies.

Key Questions Answered in this Report

  • How many companies are currently engaged in this market?
  • Which are the leading companies in this market?
  • Which cell therapy developers are most likely to collaborate with service providers?
  • What factors are likely to influence the evolution of this market?
  • What is the current and future market size?
  • What is the CAGR of this market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

Reasons to Buy this Report

  • The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
  • Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
  • The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

Additional Benefits

  • Complimentary PPT Insights Packs
  • Complimentary Excel Data Packs for all Analytical Modules in the Report
  • 15% Free Content Customization
  • Detailed Report Walkthrough Session with Research Team
  • Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Scope of the Report
  • 1.2. Research Methodology
  • 1.3. Key Questions Answered
  • 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Chapter Overview
  • 3.2. Pharmaceutical Filling and Packaging
  • 3.3. Importance of Pharmaceutical Packaging
  • 3.4. Types of Pharmaceutical Packaging
  • 3.5. Packaging of Cell Therapies
    • 3.5.1. Primary Packaging
    • 3.5.2. Secondary Packaging
  • 3.6. Cell Therapy Packaging: Key Considerations
  • 3.7. Challenges associated with Cell Therapy Packaging
  • 3.8. Concluding Remarks

4. CELL THERAPY PACKAGING SERVICE PROVIDERS: MARKET LANDSCAPE

  • 4.1. Chapter Overview
  • 4.2. Cell Therapy Packaging Service Providers: Overall Market Landscape
    • 4.2.1. Analysis by Year of Establishment
    • 4.2.2. Analysis by Company Size
    • 4.2.3. Analysis by Location of Headquarters
    • 4.2.4. Analysis by Services Offered
    • 4.2.5. Analysis by Type of Packaging
    • 4.2.6. Analysis by Type of Passive System Offered
    • 4.2.7. Analysis by Type of Package Engineering Design
    • 4.2.8. Analysis by Phase Change Material Used
    • 4.2.9. Analysis by Temperature Ranges Supported
    • 4.2.10. Analysis by Type of Cells Handled

5. CELL THERAPY PACKAGING PRODUCT PROVIDERS: MARKET LANDSCAPE

  • 5.1. Chapter Overview
  • 5.2. Cell Therapy Packaging Products: Market Landscape
    • 5.2.1. Analysis by Type of Packaging Container
    • 5.2.2. Analysis by Container Fabrication Material and Raw Materials for Container Fabrication
    • 5.2.3. Analysis by Type of Cells Packed
    • 5.2.4. Analysis by Storage Conditions
    • 5.2.5. Analysis by Usability of Container
  • 5.3. Cell Therapy Packaging: Product Providers Landscape
    • 5.3.1. Analysis by Year of Establishment
    • 5.3.2. Analysis by Company Size
    • 5.3.3. Analysis by Location of Headquarters
    • 5.3.4. Most Active Players: Distribution by Number of Products

6. CELL THERAPY PACKAGING SERVICE AND PRODUCT PROVIDERS: COMPANY PROFILES

  • 6.1. Chapter Overview
  • 6.2. Cell Therapy Packaging Service Providers
    • 6.2.1. Almac
      • 6.2.1.1. Company Overview
      • 6.2.1.2. Cell Therapy Service Portfolio
      • 6.2.1.3. Recent Developments and Future Outlook
    • 6.2.2. Catalent Biologics
      • 6.2.2.1. Company Overview
      • 6.2.2.2. Cell Therapy Service Portfolio
      • 6.2.2.3. Recent Developments and Future Outlook
    • 6.2.3. Cryoport Systems
      • 6.2.3.1. Company Overview
      • 6.2.3.2. Cell Therapy Service Portfolio
      • 6.2.3.3. Recent Developments and Future Outlook
    • 6.2.4. Yourway
      • 6.2.4.1. Company Overview
      • 6.2.4.2. Cell Therapy Service Portfolio
      • 6.2.4.3. Recent Developments and Future Outlook
  • 6.3. Cell Therapy Packaging Product Providers
    • 6.3.1. Saint-Gobain Life Sciences
      • 6.3.1.1. Company Overview
      • 6.3.1.2. Cell Therapy Packaging Product Portfolio
      • 6.3.1.3. Recent Developments and Future Outlook
    • 6.3.2. Thermo Fisher Scientific
      • 6.3.2.1. Company Overview
      • 6.3.2.2. Cell Therapy Packaging Product Portfolio
      • 6.3.2.3. Recent Developments and Future Outlook
    • 6.3.3. West Pharmaceutical Services
      • 6.3.3.1. Company Overview
      • 6.3.3.2. Cell Therapy Packaging Product Portfolio
      • 6.3.3.3. Recent Developments and Future Outlook

7. COMPANY COMPETITIVENESS ANALYSIS

  • 7.1. Chapter Overview
  • 7.2. Key Parameters
  • 7.3. Methodology
  • 7.4. Cell Therapy Packaging Service Providers: Company Competitiveness Analysis
    • 7.4.1. Companies based in North America
    • 7.4.2. Companies based in Europe and Asia-Pacific

8. PARTNERSHIPS AND COLLABORATIONS

  • 8.1. Chapter Overview
  • 8.2. Partnership Models
  • 8.3. Cell Therapy Packaging: List of Partnerships and Collaborations
    • 8.3.1. Analysis by Year of Partnership
    • 8.3.2. Analysis by Type of Partnership
    • 8.3.3. Analysis by Year and Type of Partnership
    • 8.3.4. Analysis by Purpose of Partnership
    • 8.3.5. Analysis by Type of Service(s) Covered
    • 8.3.6. Most Active Players: Analysis by Number of Partnerships
    • 8.3.7. Regional Analysis
    • 8.3.8. Intercontinental and Intracontinental Agreements

9. LIKELY PARTNER ANALYSIS

  • 9.1. Chapter Overview
  • 9.2. Scope and Methodology
  • 9.3. Potential Strategic Partners for Cell Therapy Packaging Providers in North America
    • 9.3.1. Most Likely Partners
    • 9.3.2. Likely Partners
    • 9.3.3. Less Likely Partners
  • 9.4. Potential Strategic Partners for Cell Therapy Packaging Providers in Europe
    • 9.4.1. Most Likely Partners
    • 9.4.2. Likely Partners
    • 9.4.3. Less Likely Partners
  • 9.5. Potential Strategic Partners for Cell Therapy Packaging Providers in Asia Pacific and Rest of the World
    • 9.5.1. Most Likely Partners
    • 9.5.2. Likely Partners
    • 9.5.3. Less Likely Partners

10. CELL THERAPY DEVELOPERS AND MANUFACTURERS: CASE STUDY

  • 10.1. Chapter Overview
  • 10.2. Cell Therapy Manufacturers: Overall Market Landscape
    • 10.2.1. Analysis by Year of Establishment
    • 10.2.2. Analysis by Company Size
    • 10.2.3. Analysis by Location of Headquarters
    • 10.2.4. Analysis by Location of Manufacturing Facility
    • 10.2.5. Analysis by Type of Cell(s) Manufactured
    • 10.2.6. Analysis by Source of Cells
    • 10.2.7. Analysis by Scale of Operation
    • 10.2.8. Analysis by Manufacturing Capabilities / Services
    • 10.2.9. Concluding Remarks

11. GLOBAL CELL THERAPY PACKAGING MARKET

  • 11.1. Chapter Overview
  • 11.2. Assumptions and Methodology
  • 11.3. Global Cell Therapy Packaging

Services Market, Forecasted Estimates (till 2035)

  • 11.4. Scenario Analysis
    • 11.4.1. Conservative Scenario
    • 11.4.2. Optimistic Scenario
  • 11.5. Key Market Segmentations

12. CELL THERAPY PACKAGING MARKET, BY TYPE OF THERAPY

  • 12.1. Chapter Overview
  • 12.2. Key Assumptions and Methodology
  • 12.3. Cell Therapy Packaging Market: Distribution by Type of Therapy
    • 12.3.1. T-cell Therapies Packaging: Forecasted Estimates (till 2035)
    • 12.3.2. Dendritic Cell Vaccines Packaging: Forecasted Estimates (till 2035)
    • 12.3.3. Stem Cell Therapies Packaging: Forecasted Estimates (till 2035)
    • 12.3.4. NK-Cell Therapies Packaging: Forecasted Estimates (till 2035)
    • 12.3.5. Other Advanced Therapy Medicinal Products Packaging: Forecasted Estimates (till 2035)
  • 12.4. Data Triangulation and Validation

13. CELL THERAPY PACKAGING MARKET, BY SCALE OF OPERATION

  • 13.1. Chapter Overview
  • 13.2. Key Assumptions and Methodology
  • 13.3. Cell Therapy Packaging Market: Distribution by Scale of Operation
    • 13.3.1. Clinical Scale: Forecasted Estimates (till 2035)
    • 13.3.2. Commercial Scale: Forecasted Estimates (till 2035)
  • 13.4. Data Triangulation and Validation

14. CELL THERAPY PACKAGING MARKET, BY PACKAGE ENGINEERING DESIGN

  • 14.1. Chapter Overview
  • 14.2. Key Assumptions and Methodology
  • 14.3. Cell Therapy Packaging Market: Distribution by Package Engineering Design
    • 14.3.1. Primary Packaging: Forecasted Estimates (till 2035)
    • 14.3.2. Secondary Packaging: Forecasted Estimates (till 2035)
  • 14.4. Data Triangulation and Validation

15. CELL THERAPY PACKAGING MARKET, BY KEY GEOGRAPHICAL REGIONS

  • 15.1. Chapter Overview
  • 15.2. Key Assumptions and Methodology
  • 15.3. Cell Therapy Packaging Market: Distribution by Key Geographical Regions
    • 15.3.1. North America: Forecasted Estimates (till 2035)
    • 15.3.2. Europe: Forecasted Estimates (till 2035)
    • 15.3.3. Asia-Pacific: Forecasted Estimates (till 2035)
    • 15.3.4. Rest of the World: Forecasted Estimates (till 2035)
  • 15.4. Data Triangulation and Validation

16. CONCLUDING REMARKS

  • 16.1. Chapter Overview

17. APPENDIX 1: TABULATED DATA

18. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List of Tables

  • Table 4.1 Cell Therapy Packaging Service Providers: List of Industry Players
  • Table 4.2 Cell Therapy Packaging Service Providers Market: Information on Services Offered
  • Table 4.3 Cell Therapy Packaging Service Providers Market: Information on Type of Packaging
  • Table 4.4 Cell Therapy Packaging Service Providers Market: Information on Type of Passive System Used
  • Table 4.5 Cell Therapy Packaging Service Providers Market: Information on Type of Packaging
  • Table 4.6 Cell Therapy Packaging Service Providers Market: Information on Phase Change Material
  • Table 4.7 Cell Therapy Packaging Service Providers Market: Information on Temperature Ranges
  • Table 4.8 Cell Therapy Packaging Service Providers Market: Information on Type of Cells Handled Supported
  • Table 5.1 Cell Therapy Packaging Product Providers: Information on Type of Packaging Container
  • Table 5.2 Cell Therapy Packaging Product Providers: Information on Type of Container Fabrication Material and Raw Material for Container Fabrication
  • Table 5.3 Cell Therapy Packaging Product Providers Market: Information on Type of Cells Packed
  • Table 5.4 Cell Therapy Packaging Product Providers: Information on Storage Conditions
  • Table 5.5 Cell Therapy Packaging Product Providers: Information on Packaging Volume, Customization and Usability of Container
  • Table 5.6 Cell Therapy Packaging Product Providers: List of Industry Players
  • Table 6.1 Cell Therapy Packaging Service and Product Providers: List of Companies Profiled
  • Table 6.2 Almac: Company Snapshot
  • Table 6.3 Almac: Recent Developments and Future Outlook
  • Table 6.4 Cryoport Systems: Company Snapshot
  • Table 6.5 Cryoport Systems: Recent Developments and Future Outlook
  • Table 6.6 Catalent Biologics: Company Snapshot
  • Table 6.7 Catalent Biologics: Recent Developments and Future Outlook
  • Table 6.8 Yourway: Company Snapshot
  • Table 6.9 Saint-Gobain Life Sciences: Company Snapshot
  • Table 6.10 Saint-Gobain Life Sciences: Product Portfolio
  • Table 6.11 Thermo Fisher Scientific: Company Snapshot
  • Table 6.12 Thermo Fisher Scientific: Product Portfolio
  • Table 6.13 Thermo Fisher Scientific: Recent Developments and Future Outlook
  • Table 6.14 West Pharmaceutical Services: Company Snapshot
  • Table 6.15 West Pharmaceutical Services: Product Portfolio
  • Table 6.16 West Pharmaceutical Services: Recent Developments and Future Outlook
  • Table 7.1 Cell Therapy Packaging: List of Partnerships and Collaborations, since 2016
  • Table 7.2 Partnerships and Collaborations: Information on Type of Service(s) Covered
  • Table 9.1 Most Likely Partners for Cell Therapy Packaging Product and Service Providers in North America
  • Table 9.2 Likely Partners for Cell Therapy Packaging Product and Service Providers in North America
  • Table 9.3 Less Likely Partners for Cell Therapy Packaging Product and Service Providers in North America
  • Table 9.4 Most Likely Partners for Cell Therapy Packaging Product and Service Providers in Europe
  • Table 9.5 Likely Partners for Cell Therapy Packaging Product and Service Providers in Europe
  • Table 9.6 Less Likely Partners for Cell Therapy Packaging Product and Service Providers in Europe
  • Table 9.7 Most Likely Partners for Cell Therapy Packaging Product and Service Providers in Asia Pacific and RoW
  • Table 9.8 Likely Partners for Cell Therapy Packaging Product and Service Providers in Asia Pacific and RoW
  • Table 9.9 Less Likely Partners for Cell Therapy Packaging Product and Service Providers in Asia Pacific and RoW
  • Table 10.1 Cell Therapy Manufacturers: List of Industry Players
  • Table 10.2 Cell Therapy Manufacturers: Information on Type of Cells Manufactured
  • Table 10.3 Cell Therapy Manufacturers: Information on Source of Cells
  • Table 10.4 Cell Therapy Manufacturers: Information on Scale of Operation
  • Table 10.5 Cell Therapy Manufacturers: Information on Type of Manufacturing Capabilities / Services
  • Table 17.1 Cell Therapy Packaging Service Providers: Distribution by Year of Establishment
  • Table 17.2 Cell Therapy Packaging Service Providers: Distribution by Company Size
  • Table 17.3 Cell Therapy Packaging Service Providers: Distribution by Location of Headquarters
  • Table 17.4 Cell Therapy Packaging Service Providers: Distribution by Package Engineering Design
  • Table 17.5 Cell Therapy Packaging Service Providers: Distribution by Type of Packaging
  • Table 17.6 Cell Therapy Packaging Service Providers: Distribution by Packaging Material
  • Table 17.7 Cell Therapy Packaging Service Providers: Distribution by Type of Packaging and Packaging Material
  • Table 17.8 Cell Therapy Packaging Service Providers: Distribution by Type of Passive System Used
  • Table 17.9 Cell Therapy Packaging Service Providers: Distribution by Temperature Ranges Supported
  • Table 17.10 Cell Therapy Packaging Service Providers: Distribution by Type of Packaging, Packaging Material and Temperature Ranges Supported
  • Table 17.11 Cell Therapy Packaging Service Providers: Distribution by Type of Cells Handled
  • Table 17.12 Cell Therapy Packaging Service Providers: Distribution by Type of Additional Services Offered
  • Table 17.13 Cell Therapy Packaging Products: Distribution by Type of Packaging Container
  • Table 17.14 Cell Therapy Packaging Products: Distribution by Container Fabrication Material
  • Table 17.15 Cell Therapy Packaging Products: Distribution by Type of Packaging Container and Container Fabrication Material
  • Table 17.16 Cell Therapy Packaging Products: Distribution by Storage Temperature Conditions
  • Table 17.17 Cell Therapy Packaging Products: Distribution by Type of Container and Storage Temperature Conditions
  • Table 17.18 Cell Therapy Packaging Products: Distribution by Type of Cells Packed
  • Table 17.19 Cell Therapy Packaging Products: Distribution by Usability of Container
  • Table 17.20 Cell Therapy Packaging Product Providers: Distribution by Year of Establishment
  • Table 17.21 Cell Therapy Packaging Product Providers: Distribution by Company Size
  • Table 17.22 Cell Therapy Packaging Product Providers: Distribution by Location of Headquarters
  • Table 17.23 Partnerships and Collaborations: Cumulative Year-wise Trend, since 2016
  • Table 17.24 Partnerships and Collaborations: Distribution by Type of Partnership
  • Table 17.25 Partnerships and Collaborations: Distribution by Year and Type of Partnership, since 2016
  • Table 17.26 Partnerships and Collaborations: Distribution by Purpose of Partnerships
  • Table 17.27 Partnerships and Collaborations: Distribution by Type of Service(s) Covered
  • Table 17.28 Most Active Players: Distribution by Number of Partnerships
  • Table 17.29 Partnerships and Collaborations: Distribution by Location of Parent Company
  • Table 17.30 Partnerships and Collaborations: Distribution by Location of Partner Company
  • Table 17.31 Partnerships and Collaborations: Distribution by Intercontinental and Intracontinental Partnerships
  • Table 17.32 Cell Therapy Manufacturers: Distribution by Year of Establishment
  • Table 17.33 Cell Therapy Manufacturers: Distribution by Company Size
  • Table 17.34 Cell Therapy Manufacturers: Distribution by Location of Headquarters
  • Table 17.35 Cell Therapy Manufacturers: Distribution by Location of Headquarters (Country Wise)
  • Table 17.36 Cell Therapy Manufacturers: Distribution by Location of Manufacturing Facility (Region-wise)
  • Table 17.37 Cell Therapy Manufacturers: Distribution by Location of Manufacturing Facility (Country-wise)
  • Table 17.38 Cell Therapy Manufacturers: Distribution by Type of Cells Manufactured
  • Table 17.39 Cell Therapy Manufacturers: Distribution by Type of Manufacturers
  • Table 17.40 Cell Therapy Manufacturers: Distribution by Source of Cells
  • Table 17.41 Cell Therapy Manufacturers: Distribution by Scale of Operation
  • Table 17.42 Cell Therapy Manufacturers: Distribution by Manufacturing Capabilities / Services
  • Table 17.43 Global Cell Therapy Packaging Market, Forecasted Estimates (till 2035) (USD Million)
  • Table 17.44 Global Cell Therapy Packaging Market, Forecasted Estimates (till 2035), Conservative Scenario (USD Million)
  • Table 17.45 Global Cell Therapy Packaging Market, Forecasted Estimates (till 2035), Optimistic Scenario (USD Million)
  • Table 17.46 Global Cell Therapy Packaging Market: Distribution by Type of Therapy, Current Year and 2035 (USD Million)
  • Table 17.47 Cell Therapy Packaging Market for T-cell Therapies Packaging, Forecasted Estimates (till 2035) (USD Million)
  • Table 17.48 Cell Therapy Packaging Market for Stem Cell Therapies Packaging, Forecasted Estimates (till 2035) (USD Million)
  • Table 17.49 Cell Therapy Packaging Market for Dendritic Cell Vaccines Packaging, Forecasted Estimates (till 2035) (USD Million)
  • Table 17.50 Cell Therapy Packaging Market for NK-Cell Therapies Packaging, Forecasted Estimates (till 2035) (USD Million)
  • Table 17.51 Cell Therapy Packaging Market for Other Advanced Therapy Medicinal Products Packaging, Forecasted Estimates (till 2035) (USD Million)
  • Table 17.52 Global Cell Therapy Packaging Market: Distribution by Scale of Operation, Current Year and 2035 (USD Million)
  • Table 17.53 Cell Therapy Packaging Market for Clinical Scale, Forecasted Estimates (till 2035) (USD Million)
  • Table 17.54 Cell Therapy Packaging Market for Commercial Scale, Forecasted Estimates (till 2035) (USD Million)
  • Table 17.55 Global Cell Therapy Packaging Market: Distribution by Package Engineering Design, Current Year and 2035 (USD Million)
  • Table 17.56 Cell Therapy Packaging Market for Primary Packaging, Forecasted Estimates (till 2035) (USD Million)
  • Table 17.57 Cell Therapy Packaging Market for Secondary Packaging, Forecasted Estimates (till 2035) (USD Million)
  • Table 17.58 Global Cell Therapy Packaging Market: Distribution by Key Geographical Regions, Current Year and 2035 (USD Million)
  • Table 17.59 Cell Therapy Packaging Market for North America, Forecasted Estimates (till 2035) (USD Million)
  • Table 17.60 Cell Therapy Packaging Market for Europe, Forecasted Estimates (till 2035) (USD Million)
  • Table 17.61 Cell Therapy Packaging Market for Asia-Pacific, Forecasted Estimates (till 2035) (USD Million)
  • Table 17.62 Cell Therapy Packaging Market for Rest of the World, Forecasted Estimates (till 2035) (USD Million)

List of Figures

  • Figure 2.1 Executive Summary: Service Providers Landscape
  • Figure 2.2 Executive Summary: Product Providers Landscape
  • Figure 2.3 Executive Summary: Partnerships and Collaborations
  • Figure 2.4 Executive Summary: Market Forecast and Opportunity Analysis
  • Figure 3.1 Traditional Aseptic Pharmaceutical Filling
  • Figure 3.2 Advantages of Pharmaceutical Packaging
  • Figure 3.3 Types of Pharmaceutical Packaging
  • Figure 3.4 Packaging Containers for Cell Therapies
  • Figure 3.5 Challenging aspects of Cell Therapy Packaging
  • Figure 4.1 Cell Therapy Packaging Service Providers: Distribution by Year of Establishment
  • Figure 4.2 Cell Therapy Packaging Service Providers: Distribution by Company Size
  • Figure 4.3 Cell Therapy Packaging Service Providers: Distribution by Location of Headquarters
  • Figure 4.4 Cell Therapy Packaging Service Providers: Distribution by Company Size and Location of Headquarters
  • Figure 4.5 Cell Therapy Packaging Service Providers: Distribution by Services Offered
  • Figure 4.6 Cell Therapy Packaging Service Providers: Distribution by Type of Packaging
  • Figure 4.7 Cell Therapy Packaging Service Providers: Distribution by Passive System Used
  • Figure 4.8 Cell Therapy Packaging Service Providers: Distribution by Package Engineering Design
  • Figure 4.9 Cell Therapy Packaging Service Providers: Distribution by Type of Phase Change Material
  • Figure 4.10 Cell Therapy Packaging Service Providers: Distribution by Type of Packaging and Phase Change Material
  • Figure 4.11 Cell Therapy Packaging Service Providers: Distribution by Temperature Ranges Supported
  • Figure 4.12 Cell Therapy Packaging Service Providers: Distribution by Type of Packaging, Packaging Material and Temperature Ranges Supported
  • Figure 4.13 Cell Therapy Packaging Service Providers: Distribution by Type of Cells Handled
  • Figure 5.1 Cell Therapy Packaging Products: Distribution by Type of Packaging Container
  • Figure 5.2 Cell Therapy Packaging Products: Distribution by Container Fabrication Material and Raw Materials for Container Fabrication
  • Figure 5.3 Cell Therapy Packaging Products: Distribution by Type of Packaging and Type of Container Fabrication Material
  • Figure 5.4 Cell Therapy Packaging Products: Distribution by Type of Cells Packed
  • Figure 5.5 Cell Therapy Packaging Products: Distribution by Storage Temperature
  • Figure 5.6 Cell Therapy Packaging Products: Distribution by Usability of Container
  • Figure 5.7 Cell Therapy Packaging Product Providers: Distribution by Year of Establishment
  • Figure 5.8 Cell Therapy Packaging Product Providers: Distribution by Company Size
  • Figure 5.9 Cell Therapy Packaging Product Providers: Distribution by Location of Headquarters
  • Figure 5.10 Cell Therapy Packaging Product Providers: Distribution by Company Size and Location of Headquarters
  • Figure 5.11 Key Cell Therapy Packaging Product Providers: Distribution by Number of Products
  • Figure 6.1 Almac: Cell Therapy Service Portfolio
  • Figure 6.2 Catalent Biologics: Cell Therapy Service Portfolio
  • Figure 6.3 Cryoport Systems: Cell Therapy Service Portfolio
  • Figure 6.4 Yourway: Cell Therapy Service Portfolio
  • Figure 7.1 Company Competitiveness Analysis: Cell Therapy Packaging Service Providers based in North America
  • Figure 7.2 Company Competitiveness Analysis: Cell Therapy Packaging Service Providers based in Europe and Asia-Pacific
  • Figure 8.1 Partnerships and Collaborations: Cumulative Year-wise Trend, since 2016
  • Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
  • Figure 8.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership, since 2016
  • Figure 8.4 Partnerships and Collaborations: Distribution by Purpose of Partnership
  • Figure 8.5 Partnerships and Collaborations: Distribution by Type of Service(s) Covered
  • Figure 8.6 Most Active Players: Distribution by Number of Partnerships
  • Figure 8.7 Partnerships and Collaborations: Distribution by Location of Parent Company
  • Figure 8.8 Partnerships and Collaborations: Distribution by Location of Partner Company
  • Figure 8.9 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
  • Figure 10.1 Cell Therapy Manufacturers: Distribution by Year of Establishment
  • Figure 10.2 Cell Therapy Manufacturers: Distribution by Company Size
  • Figure 10.3 Cell Therapy Manufacturers: Distribution by Location of Headquarters
  • Figure 10.4 Cell Therapy Manufacturers: Distribution by Location of Headquarters (Country Wise)
  • Figure 10.5 Cell Therapy Manufacturers: Distribution by Location of Manufacturing Facility (Region-wise)
  • Figure 10.6 Cell Therapy Manufacturers: Distribution by Location of Manufacturing Facility (Country-wise)
  • Figure 10.7 Cell Therapy Manufacturers: Distribution by Type of Cells Manufactured
  • Figure 10.8 Cell Therapy Manufacturers: Distribution by Type of Manufacturers
  • Figure 10.9 Cell Therapy Manufacturers: Distribution by Source of Cells
  • Figure 10.10 Cell Therapy Manufacturers: Distribution by Scale of Operation
  • Figure 10.11Cell Therapy Manufacturers: Distribution by Manufacturing Capabilities / Services
  • Figure 11.1 Global Cell Therapy Packaging Market, Forecasted Estimates (till 2035) (USD Million)
  • Figure 11.2 Global Cell therapy Packaging Market, Forecasted Estimates (till 2035), Conservative Scenario (USD Million)
  • Figure 11.3 Global Cell therapy Packaging Market, Forecasted Estimates (till 2035), Optimistic Scenario (USD Million)
  • Figure 12.1 Cell Therapy Packaging Market: Distribution by Type of Therapy, Current Year and 2035 (USD Million)
  • Figure 12.2 Cell Therapy Packaging Market for T-cell Therapies Packaging, Forecasted Estimates (till 2035) (USD Million)
  • Figure 12.3 Cell Therapy Packaging Market for Dendritic Cell Vaccines Packaging, Forecasted Estimates (till 2035) (USD Million)
  • Figure 12.4 Cell Therapy Packaging Market for Stem Cell Therapies Packaging, Forecasted Estimates (till 2035) (USD Million)
  • Figure 12.5 Cell Therapy Packaging Market for NK-Cell Therapies Packaging, Forecasted Estimates (till 2035) (USD Million)
  • Figure 12.6 Cell Therapy Packaging Market for Other Advanced Therapy Medicinal Products Packaging, Forecasted Estimates (till 2035) (USD Million)
  • Figure 13.1 Cell Therapy Packaging Market: Distribution by Scale of Operation, Current Year and 2035 (USD Million)
  • Figure 13.2 Cell Therapy Packaging Market for Clinical Scale, Forecasted Estimates (till 2035) (USD Million)
  • Figure 13.3 Cell Therapy Packaging Market for Commercial Scale, Forecasted Estimates (till 2035) (USD Million)
  • Figure 14.1 Cell Therapy Packaging Market: Distribution by Package Engineering Design, Current Year and 2035 (USD Million)
  • Figure 14.2 Cell Therapy Packaging Market for Primary Packaging, Forecasted Estimates (till 2035) (USD Million)
  • Figure 14.3 Cell Therapy Packaging Market for Secondary Packaging, Forecasted Estimates (till 2035) (USD Million)
  • Figure 15.1 Cell Therapy Packaging Market: Distribution by Key Geographical Regions, Current Year and 2035 (USD Million)
  • Figure 15.2 Cell Therapy Packaging Market in North America, Forecasted Estimates (till 2035) (USD Million)
  • Figure 15.3 Cell Therapy Packaging Market in Europe, Forecasted Estimates (till 2035) (USD Million)
  • Figure 15.4 Cell Therapy Packaging Market in Asia-Pacific, Forecasted Estimates (till 2035) (USD Million)
  • Figure 15.5 Cell Therapy Packaging Market in Rest of The World, Forecasted Estimates (till 2035) (USD Million)
  • Figure 16.1 Concluding Remarks: Overall Service Providers Landscape
  • Figure 16.2 Concluding Remarks: Overall Products Landscape
  • Figure 16.3 Concluding Remarks: Partnerships and Collaborations
  • Figure 16.4 Concluding Remarks: Likely Partner Analysis
  • Figure 16.5 Concluding Remarks: Market Forecast